National Bank of Canada FI Trims Position in HCA Healthcare, Inc. $HCA

National Bank of Canada FI reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.3% in the 2nd quarter, Holdings Channel.com reports. The firm owned 160,600 shares of the company’s stock after selling 10,710 shares during the quarter. National Bank of Canada FI’s holdings in HCA Healthcare were worth $61,511,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in HCA. Park Place Capital Corp grew its stake in shares of HCA Healthcare by 2,336.0% in the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after buying an additional 1,168 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after acquiring an additional 2,698 shares in the last quarter. Swiss National Bank lifted its position in shares of HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after purchasing an additional 23,100 shares in the last quarter. Cherokee Insurance Co purchased a new stake in HCA Healthcare during the 2nd quarter worth approximately $3,869,000. Finally, Harrell Investment Partners LLC boosted its position in HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after buying an additional 1,158 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $484.67 on Monday. The firm has a fifty day moving average price of $465.59 and a 200 day moving average price of $414.11. The stock has a market cap of $110.60 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.43 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the business earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 11.13%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on HCA shares. Stephens lifted their target price on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. UBS Group boosted their price objective on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. The Goldman Sachs Group lifted their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Royal Bank Of Canada lifted their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Finally, TD Cowen increased their target price on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $475.95.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.